QPS检测方法检索器
经验证的检测方法
目前用于药代动力学、药效学和免疫原性的现代生物分析方法大部分基于LC-MS/MS和免疫分析方法。 但是，对于少量重要化合物，用这些技术进行生物分析不尽人意。 一个很好的替代方法是电感耦合等离子体质谱(ICP-MS)。 在ICP-MS中，样本被电感耦合等离子体离子化（离子化源），并使用质谱仪作为分离和检测目标离子的方法。
QPS检测列表含有多种经验证的检测方法，可满足您的全部分析需求。
QPS检测列表含有多种经验证的检测方法，可满足您的全部分析需求。
点击此处搜索检测方法！
Apolipoprotein E (ApoE) (112T>C, 158C>T) Genotyping
| Matrix: | Human Whole Blood |
| Assay Range: | N/A |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | TaqMan; 7900 |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Apremilast
| Matrix: | Human Plasma |
| Assay Range: | 2 - 750 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiinflammatory |
| Classification: | Drug Assays |
Argatroban
| Matrix: | Human Plasma |
| Assay Range: | 1 - 1,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Aripiprazole
| Matrix: | Human Plasma |
| Assay Range: | 0.8 - 80 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antipsychotic |
| Classification: | Drug Assays |
Aripiprazole
Dehydroaripiprazole
Dehydroaripiprazole
| Matrix: | Human Plasma |
| Assay Range: | 1.00 - 1,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Antipsychotic |
| Classification: | Drug Assays |
Artemether
Dihydroartemesinin
Dihydroartemesinin
| Matrix: | Human Plasma |
| Assay Range: | 2.5 - 500 ng/mL2.5 - 500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antimalarial |
| Classification: | Drug Assays |
Aß 40/42 (InnoBIA-Abeta Forms)
| Matrix: | Human Plasma |
| Assay Range: | |
| Sample Volume: | |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | Luminex (2Plex) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Alzheimer's Disease |
| Classification: | Drug Assays |
Atazanavir (ATV)
| Matrix: | Human Plasma |
| Assay Range: | 20 - 8,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drug Assays |
Atazanavir (ATV)
| Matrix: | Human Plasma |
| Assay Range: | 0.01 - 5 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drug Assays |
Atazanavir Ritonavir (ATV)
| Matrix: | Human Plasma |
| Assay Range: | 10 - 5,000 ng/mL5 - 2,500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral - HIV |
| Classification: | Drug Assays |
Atomoxetine
| Matrix: | Human Plasma |
| Assay Range: | 10 - 2,400 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -30 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | ADHD |
| Classification: | Drug Assays |
Atorvastatin
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 25 ng/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | K2EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Atorvastatino-atorvastatinp-atorvastatin
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 150 ng/mL0.1 - 150 ng/mL0.05 - 20 ng/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Atorvastatino-atorvastatinp-atorvastatin
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 150 ng/mL 0.1 - 150 ng/mL 0.05 - 15 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Atorvastatino-atorvastatinp-atorvastatin
| Matrix: | Human Plasma |
| Assay Range: | 1.00 - 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Atorvastatino-atorvastatinp-atorvastatin
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
ATP-Binding Cassette Transporter Sub-family G2 (ABCG2) 421C>A Genotyping
| Matrix: | Human Whole Blood |
| Assay Range: | N/A |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Axitinib
| Matrix: | Human Plasma |
| Assay Range: | 0.1 - 120 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Axitinib
| Matrix: | Human Serum |
| Assay Range: | 0.1 - 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | NA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Azilsartan
| Matrix: | Human Plasma |
| Assay Range: | 20 - 10,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Azithromycin
| Matrix: | Human Plasma |
| Assay Range: | 2 - 400 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Azithromycin
| Matrix: | Human Plasma |
| Assay Range: | 0.500 - 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Azithromycin
| Matrix: | Human Plasma |
| Assay Range: | 0.5 - 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Benazepril
Benazeprilat
Benazeprilat
| Matrix: | Human Plasma |
| Assay Range: | 1 - 1,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Bendroflumethiazide
| Matrix: | Human Serum |
| Assay Range: | 1.00 - 200 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
点击此处下载免费的APPLE或ANDROID APP！
